Eupraxia Pharmaceuticals Inc.
EPRX.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 576.23% | 405.85% | 143.38% | 927.03% | -15.23% |
| Total Receivables | 411.29% | 178.07% | 194.54% | 32.11% | -13.27% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.17% | 182.82% | 248.92% | 105.00% | 177.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 499.24% | 396.83% | 147.12% | 824.16% | -6.91% |
|
|
|||||
| Total Current Assets | 499.24% | 396.83% | 147.12% | 824.16% | -6.91% |
| Net Property, Plant & Equipment | 342.99% | 479.41% | 132.31% | 86.55% | 54.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -30.98% | -22.94% | -20.42% | 430.43% | 1,591.30% |
| Total Assets | 492.93% | 397.22% | 146.55% | 790.98% | -5.52% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 187.03% | 229.57% | 82.93% | 63.18% | 31.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 355.56% | 285.42% | 9.18% | -3.43% | -99.24% |
| Total Finance Division Other Current Liabilities | 3,575.69% | 411.95% | 101.93% | 26.01% | -99.43% |
| Total Other Current Liabilities | 3,575.69% | 411.95% | 101.93% | 26.01% | -99.43% |
| Total Current Liabilities | 226.56% | 234.65% | 81.35% | 60.62% | -77.43% |
|
|
|||||
| Total Current Liabilities | 226.56% | 234.65% | 81.35% | 60.62% | -77.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 560.84% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 290.84% | 316.62% | 83.80% | 63.62% | -77.50% |
|
|
|||||
| Common Stock & APIC | 117.98% | 112.38% | 63.61% | 57.93% | 3.58% |
| Retained Earnings | -34.27% | -32.28% | -29.45% | -23.79% | -24.63% |
| Treasury Stock & Other | -151.57% | -8.76% | 50.87% | -17.94% | 4.51% |
| Total Common Equity | 1,212.01% | 3,583.67% | 2,977.38% | 512.62% | -161.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -6.88% | -6.20% | -6.20% | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -6.88% | -6.20% | -6.20% | -- | -- |
|
|
|||||
| Total Common Equity | 1,212.01% | 3,583.67% | 2,977.38% | 512.62% | -161.69% |
| Total Preferred Equity | -6.88% | -6.20% | -6.20% | -- | -- |
| Total Minority Interest | -1.64% | -1.67% | -1.88% | -2.78% | -5.54% |
| Total Equity | 518.15% | 403.78% | 152.67% | 1,008.61% | 57.28% |
|
|
|||||